Brief: Diagnos To Submit Future CARA Version To FDA Before End Of Q3
08/04/2026 17:16
April 8 (Reuters) - Diagnos Inc ADK.V: DIAGNOS PROVIDES AN UPDATE ON SALES AND REGULATORY ACTIVITIES FOR CARA DIAGNOS INC - TO SUBMIT FUTURE CARA VERSION TO FDA BEFORE END OF FISCAL Q3 DIAGNOS INC - TARGETS HEALTH CANADA SUBMISSION FOR CARA IN MAY 2026 DIAGNOS INC - REMAINS ENGAGED IN SAUDI FOOD AND DRUG AUTHORITY REVIEW PROCESS FOR CARA Source text: ID:nGNX3mqrXq Further company coverage: ADK.V ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Diagnos
See all newsBrief: Diagnos Submits Modified And Updated Health Canada Licence Application For Cara System Platform
Brief: Diagnos To Submit Future CARA Version To FDA Before End Of Q3
Brief: Diagnos Welcomes Dr. Pierre-Luc Charlebois To Its Advisory Board
Brief: Validated For Global Scale Diagnos Passes Annual MDSAP Audit, Solidifying The Pathway To Approvals With Health Canada & FDA
Brief: Diagnos Provides Update On Its Health Canada Medical Device Licence Application